Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proteomics | 23 | 2024 | 3618 | 1.360 |
Why?
|
Proteome | 11 | 2023 | 1790 | 0.920 |
Why?
|
Mass Spectrometry | 12 | 2021 | 2203 | 0.810 |
Why?
|
Drug Recalls | 1 | 2020 | 17 | 0.750 |
Why?
|
Pneumonia, Bacterial | 2 | 2021 | 316 | 0.680 |
Why?
|
Drug Contamination | 1 | 2020 | 148 | 0.680 |
Why?
|
Carcinogens | 1 | 2020 | 466 | 0.630 |
Why?
|
Quality Control | 1 | 2020 | 841 | 0.610 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2020 | 453 | 0.590 |
Why?
|
Cough | 1 | 2019 | 555 | 0.540 |
Why?
|
Virus Diseases | 1 | 2021 | 710 | 0.530 |
Why?
|
Phenethylamines | 1 | 2014 | 101 | 0.490 |
Why?
|
Blood Volume | 1 | 2015 | 565 | 0.480 |
Why?
|
Drug Industry | 1 | 2020 | 744 | 0.480 |
Why?
|
Malaria | 2 | 2021 | 1232 | 0.470 |
Why?
|
Drug Approval | 1 | 2020 | 740 | 0.470 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2019 | 810 | 0.440 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2014 | 215 | 0.430 |
Why?
|
Triage | 1 | 2019 | 977 | 0.430 |
Why?
|
HIV Integrase Inhibitors | 1 | 2014 | 142 | 0.430 |
Why?
|
United States Food and Drug Administration | 1 | 2020 | 1581 | 0.420 |
Why?
|
Phosphoproteins | 6 | 2021 | 2440 | 0.410 |
Why?
|
Platelet Aggregation Inhibitors | 3 | 2022 | 3067 | 0.340 |
Why?
|
Inpatients | 1 | 2020 | 2495 | 0.330 |
Why?
|
Heparin | 1 | 2015 | 1636 | 0.320 |
Why?
|
Blood Proteins | 4 | 2017 | 1122 | 0.320 |
Why?
|
Protein Processing, Post-Translational | 4 | 2023 | 1989 | 0.310 |
Why?
|
Lung Neoplasms | 7 | 2023 | 13019 | 0.270 |
Why?
|
Myocardial Infarction | 4 | 2022 | 11690 | 0.270 |
Why?
|
Pneumonia, Viral | 2 | 2021 | 3236 | 0.270 |
Why?
|
Sulfonamides | 1 | 2014 | 1932 | 0.250 |
Why?
|
Chloride Channels | 2 | 1996 | 225 | 0.250 |
Why?
|
Body Weight | 1 | 2015 | 4664 | 0.250 |
Why?
|
Veterans | 2 | 2015 | 2513 | 0.250 |
Why?
|
Insufflation | 2 | 2001 | 65 | 0.230 |
Why?
|
Chromatography, Liquid | 2 | 2018 | 977 | 0.210 |
Why?
|
Leukocytosis | 2 | 2014 | 247 | 0.210 |
Why?
|
Neoplasms | 8 | 2024 | 21596 | 0.190 |
Why?
|
Anticoagulants | 1 | 2015 | 4595 | 0.180 |
Why?
|
Peptide Fragments | 1 | 2013 | 5095 | 0.180 |
Why?
|
Respiration, Artificial | 2 | 2001 | 2566 | 0.180 |
Why?
|
Purinergic P2Y Receptor Antagonists | 2 | 2022 | 361 | 0.180 |
Why?
|
Proteins | 2 | 2023 | 6096 | 0.170 |
Why?
|
Breast Neoplasms | 8 | 2020 | 20774 | 0.170 |
Why?
|
Peptide Mapping | 2 | 2011 | 263 | 0.170 |
Why?
|
Coronary Artery Disease | 2 | 2016 | 6454 | 0.170 |
Why?
|
Gene Expression Profiling | 8 | 2018 | 9410 | 0.170 |
Why?
|
Brain Ischemia | 4 | 2014 | 3258 | 0.160 |
Why?
|
DNA Copy Number Variations | 3 | 2023 | 1940 | 0.160 |
Why?
|
Humans | 57 | 2024 | 742088 | 0.160 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2018 | 148 | 0.150 |
Why?
|
Ovarian Neoplasms | 4 | 2023 | 4823 | 0.150 |
Why?
|
Molecular Targeted Therapy | 2 | 2020 | 2723 | 0.150 |
Why?
|
Hemorrhage | 2 | 2022 | 3461 | 0.150 |
Why?
|
Biomedical Research | 1 | 2013 | 3306 | 0.150 |
Why?
|
Blood Chemical Analysis | 2 | 2011 | 440 | 0.150 |
Why?
|
Heart Failure | 1 | 2020 | 10856 | 0.140 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2018 | 890 | 0.140 |
Why?
|
Phosphorylation | 7 | 2023 | 8436 | 0.140 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2020 | 457 | 0.140 |
Why?
|
Biphenyl Compounds | 1 | 2020 | 914 | 0.140 |
Why?
|
Protein Kinases | 3 | 2020 | 1638 | 0.140 |
Why?
|
Intubation, Intratracheal | 2 | 2001 | 1357 | 0.130 |
Why?
|
Lung Injury | 1 | 2001 | 436 | 0.130 |
Why?
|
Stents | 2 | 2018 | 3276 | 0.130 |
Why?
|
Receptor, erbB-2 | 3 | 2020 | 2410 | 0.130 |
Why?
|
Drug Combinations | 1 | 2020 | 1961 | 0.130 |
Why?
|
Retina | 2 | 1996 | 2611 | 0.130 |
Why?
|
Tetrazoles | 1 | 2020 | 835 | 0.130 |
Why?
|
Morpholines | 1 | 2018 | 561 | 0.130 |
Why?
|
Molecular Sequence Annotation | 2 | 2016 | 527 | 0.120 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2020 | 923 | 0.120 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2015 | 361 | 0.120 |
Why?
|
Aminopyridines | 1 | 2018 | 541 | 0.120 |
Why?
|
Plasma | 1 | 2017 | 575 | 0.120 |
Why?
|
Cold Ischemia | 1 | 2014 | 65 | 0.120 |
Why?
|
Workflow | 4 | 2023 | 846 | 0.120 |
Why?
|
Retinal Rod Photoreceptor Cells | 1 | 1995 | 195 | 0.120 |
Why?
|
Pathology, Molecular | 1 | 2017 | 325 | 0.120 |
Why?
|
Antibodies, Bacterial | 1 | 2019 | 1469 | 0.110 |
Why?
|
Medulloblastoma | 1 | 2018 | 681 | 0.110 |
Why?
|
Oxazines | 1 | 2014 | 298 | 0.110 |
Why?
|
Mutation | 5 | 2021 | 29717 | 0.110 |
Why?
|
gamma-Aminobutyric Acid | 2 | 1996 | 1123 | 0.110 |
Why?
|
Piperazines | 2 | 2014 | 2488 | 0.110 |
Why?
|
Simvastatin | 1 | 2015 | 360 | 0.110 |
Why?
|
Drug Interactions | 2 | 2014 | 1458 | 0.110 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2018 | 3557 | 0.110 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2020 | 1581 | 0.100 |
Why?
|
Receptors, GABA-A | 1 | 1996 | 627 | 0.100 |
Why?
|
Glycine | 1 | 1995 | 671 | 0.100 |
Why?
|
Computational Biology | 3 | 2018 | 3518 | 0.100 |
Why?
|
Point-of-Care Systems | 1 | 2019 | 1175 | 0.100 |
Why?
|
Aged, 80 and over | 8 | 2021 | 57683 | 0.090 |
Why?
|
Aged | 13 | 2022 | 162944 | 0.090 |
Why?
|
Acetanilides | 1 | 2012 | 168 | 0.090 |
Why?
|
Ticlopidine | 1 | 2016 | 899 | 0.090 |
Why?
|
Genomics | 4 | 2024 | 5692 | 0.090 |
Why?
|
Stroke | 4 | 2014 | 9963 | 0.090 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2014 | 790 | 0.090 |
Why?
|
Pyridones | 1 | 2014 | 712 | 0.090 |
Why?
|
Blood Coagulation | 1 | 2015 | 1126 | 0.090 |
Why?
|
Acetylation | 2 | 2023 | 1085 | 0.090 |
Why?
|
Cohort Studies | 4 | 2022 | 40450 | 0.090 |
Why?
|
Influenza, Human | 1 | 2020 | 1472 | 0.090 |
Why?
|
Female | 26 | 2023 | 379592 | 0.080 |
Why?
|
DNA Methylation | 2 | 2020 | 4282 | 0.080 |
Why?
|
Papillomavirus Infections | 1 | 2021 | 1585 | 0.080 |
Why?
|
Nervous System | 1 | 2012 | 553 | 0.080 |
Why?
|
Specimen Handling | 1 | 2013 | 692 | 0.080 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2016 | 1873 | 0.080 |
Why?
|
Patient Education as Topic | 1 | 2018 | 2275 | 0.080 |
Why?
|
Pneumonia | 2 | 2017 | 2117 | 0.080 |
Why?
|
Signal Transduction | 7 | 2021 | 23387 | 0.080 |
Why?
|
Anticholesteremic Agents | 1 | 2015 | 979 | 0.080 |
Why?
|
Stroke Volume | 1 | 2020 | 4983 | 0.080 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2021 | 8425 | 0.080 |
Why?
|
Male | 17 | 2023 | 349538 | 0.070 |
Why?
|
Medication Adherence | 1 | 2018 | 2055 | 0.070 |
Why?
|
Respiratory Mechanics | 2 | 2001 | 681 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2021 | 4029 | 0.070 |
Why?
|
Neoplasm Proteins | 2 | 2021 | 3691 | 0.070 |
Why?
|
United States | 6 | 2021 | 69693 | 0.070 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2015 | 1263 | 0.070 |
Why?
|
Retrospective Studies | 8 | 2022 | 77098 | 0.070 |
Why?
|
Smoking | 2 | 2021 | 8969 | 0.070 |
Why?
|
Reproducibility of Results | 7 | 2016 | 19862 | 0.060 |
Why?
|
Lung | 2 | 2020 | 9826 | 0.060 |
Why?
|
Biological Assay | 1 | 2008 | 652 | 0.060 |
Why?
|
Disability Evaluation | 1 | 2012 | 1827 | 0.060 |
Why?
|
Phenotype | 2 | 2020 | 16331 | 0.060 |
Why?
|
Protein Array Analysis | 1 | 2006 | 411 | 0.060 |
Why?
|
Cluster Analysis | 3 | 2021 | 2713 | 0.060 |
Why?
|
Treatment Outcome | 6 | 2022 | 62966 | 0.060 |
Why?
|
Middle Aged | 11 | 2021 | 213127 | 0.060 |
Why?
|
Patient Selection | 1 | 2015 | 4214 | 0.050 |
Why?
|
United States Department of Veterans Affairs | 2 | 2018 | 874 | 0.050 |
Why?
|
Databases, Protein | 2 | 2018 | 383 | 0.050 |
Why?
|
Neoplasm Transplantation | 2 | 2018 | 2085 | 0.050 |
Why?
|
Fallopian Tubes | 1 | 2023 | 182 | 0.050 |
Why?
|
Peptides | 4 | 2023 | 4392 | 0.050 |
Why?
|
Nervous System Diseases | 1 | 2012 | 1617 | 0.050 |
Why?
|
Acute Coronary Syndrome | 1 | 2015 | 2337 | 0.050 |
Why?
|
Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2021 | 42 | 0.050 |
Why?
|
Cell Line, Tumor | 5 | 2018 | 16665 | 0.050 |
Why?
|
Barotrauma | 1 | 2001 | 37 | 0.050 |
Why?
|
Acidosis, Respiratory | 1 | 2001 | 37 | 0.050 |
Why?
|
High-Frequency Jet Ventilation | 1 | 2001 | 23 | 0.050 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2021 | 180 | 0.050 |
Why?
|
Tumor Escape | 1 | 2024 | 349 | 0.050 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2023 | 338 | 0.050 |
Why?
|
Embolism, Air | 1 | 2001 | 111 | 0.050 |
Why?
|
High-Frequency Ventilation | 1 | 2001 | 87 | 0.050 |
Why?
|
Systems Integration | 2 | 2013 | 440 | 0.050 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2005 | 602 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2007 | 3920 | 0.050 |
Why?
|
Genome, Human | 1 | 2013 | 4420 | 0.050 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 3239 | 0.050 |
Why?
|
Pattern Recognition, Automated | 1 | 2006 | 996 | 0.040 |
Why?
|
Sequence Analysis, RNA | 2 | 2018 | 2011 | 0.040 |
Why?
|
Rabbits | 2 | 1996 | 4886 | 0.040 |
Why?
|
Carboplatin | 1 | 2022 | 799 | 0.040 |
Why?
|
Hypercapnia | 1 | 2001 | 260 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2021 | 322 | 0.040 |
Why?
|
Risk Assessment | 1 | 2020 | 23320 | 0.040 |
Why?
|
Animals | 12 | 2018 | 168561 | 0.040 |
Why?
|
RNA, Neoplasm | 1 | 2001 | 768 | 0.040 |
Why?
|
Tidal Volume | 1 | 2001 | 489 | 0.040 |
Why?
|
Leukemia | 1 | 2007 | 1507 | 0.040 |
Why?
|
Ventilators, Mechanical | 1 | 2001 | 292 | 0.040 |
Why?
|
Risk Factors | 4 | 2020 | 72145 | 0.040 |
Why?
|
Adult | 7 | 2021 | 213712 | 0.040 |
Why?
|
DNA-Activated Protein Kinase | 1 | 2018 | 117 | 0.040 |
Why?
|
Child | 3 | 2021 | 77478 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2021 | 535 | 0.040 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2001 | 363 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2018 | 2938 | 0.040 |
Why?
|
Oncogenes | 1 | 2023 | 1263 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2018 | 8829 | 0.040 |
Why?
|
Retinoblastoma Protein | 1 | 2020 | 701 | 0.040 |
Why?
|
Ubiquitination | 1 | 2021 | 1011 | 0.040 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinase 2 | 1 | 2016 | 33 | 0.040 |
Why?
|
Positive-Pressure Respiration | 1 | 2001 | 632 | 0.040 |
Why?
|
Models, Genetic | 1 | 2007 | 3493 | 0.040 |
Why?
|
Mutagenesis | 1 | 2020 | 1263 | 0.040 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2021 | 713 | 0.040 |
Why?
|
S-Phase Kinase-Associated Proteins | 1 | 2016 | 90 | 0.030 |
Why?
|
Receptors, Interleukin-10 | 1 | 2016 | 50 | 0.030 |
Why?
|
Focal Adhesion Kinase 1 | 1 | 2016 | 120 | 0.030 |
Why?
|
Pilot Projects | 3 | 2020 | 8297 | 0.030 |
Why?
|
Sensitivity and Specificity | 4 | 2016 | 14720 | 0.030 |
Why?
|
Mice | 7 | 2018 | 81045 | 0.030 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2016 | 141 | 0.030 |
Why?
|
p21-Activated Kinases | 1 | 2016 | 128 | 0.030 |
Why?
|
Immunotherapy | 2 | 2021 | 4414 | 0.030 |
Why?
|
Haptoglobins | 1 | 2016 | 165 | 0.030 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2016 | 403 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13655 | 0.030 |
Why?
|
National Human Genome Research Institute (U.S.) | 1 | 2013 | 23 | 0.030 |
Why?
|
Insurance Claim Review | 1 | 2018 | 720 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2018 | 1661 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2016 | 357 | 0.030 |
Why?
|
Hedgehog Proteins | 1 | 2018 | 781 | 0.030 |
Why?
|
src-Family Kinases | 1 | 2016 | 551 | 0.030 |
Why?
|
Drug Therapy, Combination | 2 | 2015 | 6483 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2023 | 2940 | 0.030 |
Why?
|
Histones | 1 | 2023 | 2597 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2018 | 987 | 0.030 |
Why?
|
Transcription, Genetic | 1 | 2007 | 7721 | 0.030 |
Why?
|
Patch-Clamp Techniques | 1 | 1995 | 963 | 0.030 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2016 | 670 | 0.030 |
Why?
|
Cyclic AMP | 1 | 1996 | 1470 | 0.030 |
Why?
|
Equipment Design | 1 | 2001 | 3582 | 0.030 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2013 | 281 | 0.030 |
Why?
|
Mass Screening | 1 | 2008 | 5238 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2018 | 944 | 0.030 |
Why?
|
Down-Regulation | 1 | 2020 | 3001 | 0.030 |
Why?
|
Gene Library | 1 | 2015 | 1076 | 0.030 |
Why?
|
Isotope Labeling | 1 | 2014 | 414 | 0.030 |
Why?
|
Immunoassay | 1 | 2016 | 752 | 0.030 |
Why?
|
Metabolomics | 1 | 2020 | 1467 | 0.030 |
Why?
|
Membrane Potentials | 1 | 1995 | 1135 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2024 | 8621 | 0.030 |
Why?
|
Neoadjuvant Therapy | 1 | 2022 | 2721 | 0.030 |
Why?
|
Benchmarking | 1 | 2018 | 1038 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2018 | 1525 | 0.020 |
Why?
|
Prognosis | 3 | 2021 | 29010 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 2016 | 1400 | 0.020 |
Why?
|
DNA Repair | 1 | 2020 | 2042 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 2016 | 1081 | 0.020 |
Why?
|
Infant | 3 | 2018 | 35070 | 0.020 |
Why?
|
Nitroglycerin | 1 | 2012 | 325 | 0.020 |
Why?
|
Algorithms | 2 | 2013 | 13853 | 0.020 |
Why?
|
DNA Damage | 1 | 2020 | 2423 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2020 | 2107 | 0.020 |
Why?
|
Severity of Illness Index | 3 | 2012 | 15530 | 0.020 |
Why?
|
Research Design | 2 | 2018 | 5979 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2018 | 9941 | 0.020 |
Why?
|
Child, Preschool | 3 | 2018 | 40955 | 0.020 |
Why?
|
Sample Size | 1 | 2013 | 844 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2014 | 1875 | 0.020 |
Why?
|
Protein Binding | 1 | 2021 | 9387 | 0.020 |
Why?
|
RNA Interference | 1 | 2018 | 2890 | 0.020 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2016 | 1221 | 0.020 |
Why?
|
Hospital Mortality | 2 | 2012 | 5310 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 3504 | 0.020 |
Why?
|
Gene Expression | 1 | 2001 | 7790 | 0.020 |
Why?
|
Calcium Channel Blockers | 1 | 2012 | 689 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 3564 | 0.020 |
Why?
|
HIV Infections | 1 | 2014 | 16678 | 0.020 |
Why?
|
Area Under Curve | 1 | 2012 | 1653 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2015 | 1780 | 0.020 |
Why?
|
Blood Glucose | 2 | 2012 | 6249 | 0.020 |
Why?
|
Cattle | 1 | 2014 | 3923 | 0.020 |
Why?
|
Tissue Plasminogen Activator | 1 | 2014 | 1262 | 0.020 |
Why?
|
Young Adult | 3 | 2021 | 56350 | 0.020 |
Why?
|
Patient Care Team | 1 | 2018 | 2527 | 0.020 |
Why?
|
Vasodilator Agents | 1 | 2012 | 976 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2001 | 13029 | 0.020 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2012 | 1239 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2014 | 2382 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39004 | 0.020 |
Why?
|
Normal Distribution | 1 | 2006 | 280 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3510 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2016 | 2948 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2012 | 1548 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2018 | 18006 | 0.020 |
Why?
|
Thrombolytic Therapy | 1 | 2014 | 2161 | 0.020 |
Why?
|
ROC Curve | 1 | 2012 | 3528 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2020 | 5522 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2001 | 6347 | 0.010 |
Why?
|
Calibration | 1 | 2006 | 815 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2012 | 4929 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2018 | 5851 | 0.010 |
Why?
|
Genes, p53 | 1 | 2005 | 755 | 0.010 |
Why?
|
Hospitalization | 2 | 2012 | 10232 | 0.010 |
Why?
|
Species Specificity | 1 | 2007 | 2479 | 0.010 |
Why?
|
Rats | 1 | 2018 | 24265 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 11472 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 1995 | 11363 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 2013 | 2542 | 0.010 |
Why?
|
Disease Progression | 2 | 2012 | 13256 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2016 | 12958 | 0.010 |
Why?
|
Odds Ratio | 1 | 2012 | 9846 | 0.010 |
Why?
|
Cells, Cultured | 1 | 1995 | 19223 | 0.010 |
Why?
|
Patient Discharge | 1 | 2012 | 3300 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2012 | 10943 | 0.010 |
Why?
|
Carcinoma, Small Cell | 1 | 2001 | 420 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 12946 | 0.010 |
Why?
|
Length of Stay | 1 | 2012 | 6294 | 0.010 |
Why?
|
Electrocardiography | 1 | 2012 | 6440 | 0.010 |
Why?
|
Logistic Models | 1 | 2012 | 13403 | 0.010 |
Why?
|
Genome | 1 | 2005 | 1803 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2007 | 2714 | 0.010 |
Why?
|
Chronic Disease | 1 | 2012 | 9144 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2017 | 25575 | 0.010 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2005 | 1515 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 15056 | 0.010 |
Why?
|
Time Factors | 2 | 2012 | 40054 | 0.010 |
Why?
|
Age Factors | 1 | 2012 | 18355 | 0.010 |
Why?
|
Prospective Studies | 1 | 2018 | 53187 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2006 | 3584 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2007 | 14554 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2001 | 4839 | 0.010 |
Why?
|
Adolescent | 1 | 2018 | 85649 | 0.010 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2005 | 3497 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2006 | 21821 | 0.000 |
Why?
|
Survival Rate | 1 | 2001 | 12773 | 0.000 |
Why?
|